| | ENG

For Investigators Only

CN102b: Phase I/II UCBMC Transplant Trial
This umbilical cord blood mononuclear cell transplant trial is eligible to assess the safety and feasibility of transplanting cord blood mononuclear cells into chronic spinal cord injury patients. The trial started in Jan 2010 in Hong Kong and completed at the end of 2013.

Participating Sites (listed in no particular order): The University of Hong Kong/Queen Mary Hospital and The Chinese University of Hong Kong/Prince of Wales Hospital.

Principal Investigators (listed in no particular order): Dr. Gilberto LEUNG and Dr. Wai Sang POON

No. of Subjects enrolled: 8

Sponsorship (listed in no particular order): Hong Kong Spinal Cord Injury Fund and Stemcyte Inc.

For more information, please refer to:

Clinicaltrials.gov: NCT01046786

What should I do if I would like to participate in the trials of ChinaSCINet?
To learn as much as possible about the clinical trial and then contact the investigator directly. You may also leave your basic information and contact here (Submit a Form). The investigators may retrieve the data and contact you if they think you might be suitable candidate for the trial.

To read more:

About Clinical Research

About Lithium and Cord Blood Cells

Copyright © 2020. CHINASCINET
About Us | SCI Info | Studies | Events | ISCITT | Contact